Navigation Links
Looking Towards More Effective Leukemia Treatment

Eighty percent of the time childhood acute lymphoblastic leukemia is curable with chemotherapy. The bad news is doctors are not sure // why it doesn’t work for the other 20 percent of patients. Now, new research finds it could be because of a small number of genes that are resistant to drugs used to treat the disease.

Researchers tested leukemia cells from 173 children. They looked at the sensitivity of the cells to four different treatment drugs. The cells were then assessed to identify which ones were drug-sensitive and which ones were drug-resistant. The gene-expression patterns were then compared with the original 173 patients and 98 children from another institution.

Researchers identified a number of different genes that were resistant to each of the four drugs. They found the patients with more of the resistant genes were less likely to respond to treatment. Researchers say of the 124 genes identified, 121 have not previously been associated with resistance to the four chemotherapy drugs.

Thus researchers conclude saying that a relatively small number of genes can play a role in the resistance to treatment for children with acute lymphoblastic leukemia.
'"/>




Page: 1

Related medicine news :

1. Palmist Claims to Diagnose Ailments Looking At Your Palm
2. Plastic Surgeons Looking Forward To First Full Face Transplant
3. Looking For A Friend Or Life Partner? Join A Gym
4. Researchers Looking for Genes That Control the Brain
5. Attitude Towards AIDS Patients – Time For A Change
6. Scientists Awarded Appropriately For Contribution Towards Medical Research
7. A Step Towards Unraveling The Schizophrenia And Depression Mystery
8. Are Women Not Hearty Enough Towards Seeking Heart Care?
9. RPB grants $7.9 Million Towards Research
10. Blood Transfusion May Have Contributed Towards Hepatitis C
11. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology: